Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Interest & Investment Income of -$78000.0 for Q1 2026, down 100.35% on a QoQ basis from $22.3 million in Q4 2025, and down 172.9% year-over-year from $107000.0 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$78000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 172.9% year-over-year to -$78000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (down 42.32% YoY) and the FY2025 annual result came in at $22.6 million, down 41.43% from the prior year.
- Interest & Investment Income was -$78000.0 for Q1 2026 at Ginkgo Bioworks Holdings, down from $22.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $38.6 million in Q4 2024 and bottomed at -$78000.0 in Q1 2026.
- A 3-year average of $12.2 million and a median of $316000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income sank 42.31% — and 2026, when it plunged 172.9%.
- Ginkgo Bioworks Holdings' Interest & Investment Income stood at $38.6 million in 2024, then tumbled by 42.31% to $22.3 million in 2025, then plunged by 100.35% to -$78000.0 in 2026.
- Business Quant data shows DNA's Interest & Investment Income at -$78000.0 in Q1 2026, $22.3 million in Q4 2025, and $316000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Ginkgo Bioworks Holdings | 445.24 Mn | 301.37 Mn | 16.38 Mn | -78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78,000.00 |
| Dec 31, 2025 | 22.28 Mn |
| Sep 30, 2025 | 316,000.00 |
| Mar 31, 2025 | 107,000.00 |
| Dec 31, 2024 | 38.61 Mn |
| Dec 31, 2021 | 496,000.00 |
| Sep 30, 2021 | 121,000.00 |
| Dec 31, 2020 | -2.98 Mn |
| Sep 30, 2020 | 3.32 Mn |